ArticleOncoimmunology2024

Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma.

Jonathan G Pol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.